About Renasant Bio
Renasant Bio is a private company based in Berkeley, California, incorporated in 2022 in Delaware. It has reported $55,461,184 raised in two offerings on Form D since July 2025. Its chief executive is Emily Conley.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 3, 2025 | Jul 14, 2025 | $30,000,000fully sold | 4 | $7.5M | EquityRule 506(b) | Form D ↗ |
| Jul 15, 2024 | Jul 14, 2025 | $25,461,184fully sold | 3 | $8.4M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $55,461,184 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Renasant Bio's Form D filed Jul 14, 2025.
EC
Evan Caplan
Director
NH
Natalie Holles
Director
CM
Charlotte McKee
Director
DP
Deborah Palestrant
Director
TG
Thomas Gustafson
Executive officer
KB
Kevin Bitterman
Director
EC
Emily Conley
CEO and director
Earlier filings also listed June Lee (director, last listed Jul 2025).